Editorial: Dyslipidemia, obesity and coronavirus disease 2019 (COVID-19).
作者信息
Hariyanto Timotius Ivan, Kurniawan Andree, Tahapary Dicky Levenus
机构信息
Faculty of Medicine, Pelita Harapan University, Tangerang, Indonesia.
Department of Internal Medicine, Faculty of Medicine, Pelita Harapan University, Tangerang, Indonesia.
出版信息
Front Nutr. 2022 Nov 23;9:1019970. doi: 10.3389/fnut.2022.1019970. eCollection 2022.
Abstract
摘要
相似文献
1
Editorial: Dyslipidemia, obesity and coronavirus disease 2019 (COVID-19).社论：血脂异常、肥胖与2019冠状病毒病（COVID-19）
Front Nutr. 2022 Nov 23;9:1019970. doi: 10.3389/fnut.2022.1019970. eCollection 2022.
2
A Review of COVID-19 in Relation to Metabolic Syndrome: Obesity, Hypertension, Diabetes, and Dyslipidemia.与代谢综合征相关的2019冠状病毒病综述：肥胖、高血压、糖尿病和血脂异常
Cureus. 2022 Jul 29;14(7):e27438. doi: 10.7759/cureus.27438. eCollection 2022 Jul.
3
Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection.血脂异常与2019冠状病毒病（COVID-19）重症感染相关。
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):1463-1465. doi: 10.1016/j.dsx.2020.07.054. Epub 2020 Aug 1.
4
The impact of obesity and dyslipidemia on Remdesivir effectiveness in hospitalized patients with SARS-CoV-2-related pneumonia: An observational study.肥胖和血脂异常对住院的 SARS-CoV-2 相关肺炎患者瑞德西韦疗效的影响：一项观察性研究。
Nutr Metab Cardiovasc Dis. 2022 Jul;32(7):1635-1641. doi: 10.1016/j.numecd.2022.04.005. Epub 2022 Apr 10.
5
Diet-Induced Obesity and NASH Impair Disease Recovery in SARS-CoV-2-Infected Golden Hamsters.饮食诱导的肥胖和 NASH 损害感染 SARS-CoV-2 的金黄地鼠的疾病恢复。
Viruses. 2022 Sep 17;14(9):2067. doi: 10.3390/v14092067.
6
Association of prior metabolic and bariatric surgery with severity of coronavirus disease 2019 (COVID-19) in patients with obesity.肥胖患者既往代谢和减重手术与 2019 年冠状病毒病（COVID-19）严重程度的关联。
Surg Obes Relat Dis. 2021 Jan;17(1):208-214. doi: 10.1016/j.soard.2020.10.026. Epub 2020 Nov 23.
7
Alteration of the gut microbiota's composition and metabolic output correlates with COVID-19-like severity in obese NASH hamsters.肠道微生物组的组成和代谢产物的改变与肥胖 NASH 仓鼠的 COVID-19 样严重程度相关。
Gut Microbes. 2022 Jan-Dec;14(1):2100200. doi: 10.1080/19490976.2022.2100200.
8
Persistence of SARS-CoV-2 RNA in a male with metabolic syndrome for 72 days: A case report.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）RNA在一名患有代谢综合征的男性体内持续存在72天：病例报告
SAGE Open Med Case Rep. 2021 Jan 23;9:2050313X21989492. doi: 10.1177/2050313X21989492. eCollection 2021.
9
Association of dyslipidemia with the severity and mortality of coronavirus disease 2019 (COVID-19): a meta-analysis.血脂异常与 2019 年冠状病毒病（COVID-19）严重程度和死亡率的关系：一项荟萃分析。
Virol J. 2021 Jul 27;18(1):157. doi: 10.1186/s12985-021-01604-1.
10
COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology.2019冠状病毒病与内分泌疾病。欧洲内分泌学会声明。
Endocrine. 2020 Apr;68(1):2-5. doi: 10.1007/s12020-020-02294-5.
引用本文的文献
1
Management of dyslipidemia in special groups.特殊人群的血脂异常管理。
Indian Heart J. 2024 Mar;76 Suppl 1(Suppl 1):S96-S100. doi: 10.1016/j.ihj.2024.01.018. Epub 2024 Feb 8.
本文引用的文献
1
Novel coronavirus pathogen in humans and animals: an overview on its social impact, economic impact, and potential treatments.人类和动物中的新型冠状病毒病原体：对其社会影响、经济影响和潜在治疗方法的概述。
Environ Sci Pollut Res Int. 2021 Dec;28(48):68071-68089. doi: 10.1007/s11356-021-16809-8. Epub 2021 Oct 18.
2
Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients.COVID-19 相关死亡风险因素：42 项研究和 423117 例患者的系统评价和荟萃分析。
BMC Infect Dis. 2021 Aug 21;21(1):855. doi: 10.1186/s12879-021-06536-3.
Zotero 插件